| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TAX PREP | 900 | 900 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| .505 PUBLIC STORAGE INC | 2019-09 | PURCHASE | 2020-03 | 102 | 125 | -23 | ||||
| .684 ABBIVE INC | 2015-08 | PURCHASE | 2020-03 | 51 | 47 | 4 | ||||
| .972 ENTERPRISE PROD | 2000-09 | PURCHASE | 2020-03 | 13 | 5 | 8 | ||||
| .376 OMEGA HEALTHCARE | 2015-05 | PURCHASE | 2020-03 | 10 | 13 | -3 | ||||
| ENT PRODUCTS 1231 LOSS | 2000-09 | PURCHASE | 2020-12 | 423 | -423 | |||||
| ENT PRODUCTS 1231 LOSS | 2000-09 | PURCHASE | 2020-12 | 708 | -708 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| WELLS FARGO INVESTMENTS | ||
| MORGAN STANLEY INVESTMENTS | 221,712 | 207,495 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ENTERPRISE PRODUCT PARTNES K-1 | AT COST | ||
| ENTERPRISE PRODUCT PARTNERSHIP | AT COST |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| LOSS ON PASS THRU ENTR PROD(1 | 11,718 | 11,718 | ||
| LOSS ON PASS THRU ENT PROD (2 | 16,727 | 16,727 | ||
| BROKER FEE | 175 | 175 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| NEGATIVE BOOK VALUE OF INVESTMENT | 81,364 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXCISE TAX | 473 | 473 |